Thalomid (Thalidomide) for Lymphoma

Overview
Thalomid, also known by its drug name thalidomide, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat, in conjunction with dexamethasone, newly diagnosed multiple myeloma. Thalomid is sometimes prescribed off-label to treat non-Hodgkin lymphoma after other therapies have failed.

Thalomid is an immunomodulator — a drug that modulates the immune system. Thalomid is believed to work by interacting with the immune system to reduce inflammation.

How do I take it?
Thalomid is taken orally. Thalomid comes in the form of a capsule.

Side effects
The FDA-approved label for Thalomid lists common side effects including fatigue, fever, anxiety, agitation, confusion, dizziness, dry skin, trouble breathing, muscle weakness, tremors, nausea, constipation, loss of appetite, weight changes, neuropathy (pain, numbness, or tingling in the limbs), low calcium levels, and blood clots.

Rare but serious side effects listed for Thalomid include fetal harm in pregnant individuals, nerve damage, heart attack, stroke, bradycardia (slowed heart rate), severe skin reactions, and hypersensitivity reactions.

For more details about this treatment, visit:

Thalomid — Celgene
https://www.thalomid.com

Chemotherapy for Non-Hodgkin Lymphoma — American Cancer Society
https://www.cancer.org/cancer/non-hodgkin-lymph...

Drug Therapy for Multiple Myeloma — American Cancer Society
https://www.cancer.org/cancer/multiple-myeloma/...